News

Lannett Company, Inc. announced that it has entered into a settlement and license agreement with Celgene Corporation that resolves patent infringement litigation in the U.S. related to…
Read More...

Xynomic Pharma announced that it has acquired exclusive global rights to develop, manufacture and commercialize BI 882370, a 2nd-generation RAF inhibitor, from Boehringer Ingelheim, a…
Read More...

Evotec AG and TESARO, Inc. announced a three-year integrated drug discovery collaboration to discover and develop novel small molecule product candidates against an undisclosed…
Read More...

BioMarin Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) granted valoctocogene roxaparvovec (formerly BMN 270) Breakthrough Therapy Designation. The FDA's…
Read More...

PDL BioPharma announced that it has submitted a proposal to acquire Neos Therapeutics for $10.25per share in cash. This all-cash transaction represents a premium of 40% to the…
Read More...

Artemis Therapeutics announced the appointment of Brian M. Culley, M.A., M.B.A. as its Chief Executive Officer. Mr. Culley is an entrepreneurial and innovative biotech executive with 25…
Read More...

Incyte Corporation and MacroGenics, Inc. announced that the companies have entered into an exclusive global collaboration and license agreement for MacroGenics’ MGA012, an…
Read More...

Ortek Therapeutics announced that the Ortek ECD™ received 510(k) clearance from the U.S. Food and Drug Administration. The ECD is a patented lightweight tabletop device designed as an…
Read More...

TiGenix NV announces that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Cx601 for the treatment of patients with fistulizing Crohns disease.…
Read More...

Imprimis Pharmaceuticals announced that it is making compounded Cyclosporine-based formulations available for physicians to consider prescribing as customizable and potentially…
Read More...

Catalent announced that it has completed the acquisition of Cook Pharmica LLC, an integrated provider of drug substance and drug product manufacturing and related services. The…
Read More...

Recipharm has equipped its sixth facility with serialisation capabilities ahead of the US and European regulation enforcement deadlines. The facility in Lisbon is the latest of…
Read More...

Vetter announced a major expansion of its secondary packaging capacities as a response to rising customer needs and market demands for complex packaging solutions. The need for…
Read More...

Quotient Clinical announced that it has signed an agreement with Nuformix Technologies Limited (a wholly owned subsidiary of Nuformix plc, ‘Nuformix’), to evaluate the clinical…
Read More...

Alcami Corporation announces the launch of its international sales office in Tokyo, Japan. The company is expanding its presence in Japan to remain at the forefront of market demands…
Read More...

Servier CDMO announces that the company has invested $7.5 million USD in intensified technology included continuous chromatography with simulated moving beds (SMB) and super critical…
Read More...

Merck announced that its Carlsbad, California-based manufacturing facility for the production of BioReliance viral and gene therapy products has completed both a U.S. Food & Drug…
Read More...

Agenus announced the launch of a subsidiary company for its cell therapy business, AgenTus Therapeutics, Inc. The subsidiary is focused on realizing significant value for both…
Read More...

Eli Lilly and Company announced plans to invest $72 million in an insulin manufacturing project at one of its Indianapolis facilities. The investment will be used to replace an existing…
Read More...

TiGenix NV, an advanced biopharmaceutical company focused on exploiting the anti-inflammatory properties of allogeneic, or donor-derived, stem cells to develop novel therapies for…
Read More...